Volume 120, Issue 11, Supplement 1 , Pages S1-S21, November 2007
Hyponatremia Treatment Guidelines 2007: Expert Panel Recommendations
Abstract
Although hyponatremia is a common, usually mild, and relatively asymptomatic disorder of electrolytes, acute severe hyponatremia can cause substantial morbidity and mortality, particularly in patients with concomitant disease. In addition, overly rapid correction of chronic hyponatremia can cause severe neurologic deficits and death, and optimal treatment strategies for such cases are not established. An expert panel assessed the potential contributions of aquaretic nonpeptide small-molecule arginine vasopressin receptor (AVPR) antagonists to hyponatremia therapies. This review presents their conclusions, including identification of appropriate treatment populations and possible future indications for aquaretic AVPR antagonists.
Keywords: Antidiuretic hormone, Aquaretics, Hypo-osmolality, Natriuresis, Syndrome of inappropriate antidiuretic hormone secretion, Vasopressin
To access this article, please choose from the options below
Statement of author disclosure: Please see the Author Disclosure section at the end of this article.
PII: S0002-9343(07)00845-5
doi:10.1016/j.amjmed.2007.09.001
© 2007 Elsevier Inc. All rights reserved.
Volume 120, Issue 11, Supplement 1 , Pages S1-S21, November 2007

